Current treatment paradigms and emerging therapies for NAFLD/NASH-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current treatment paradigms and emerging therapies for NAFLD/NASH

Published:2021 Issue:2 Volume:26 Page:206-237
ISSN:1093-9946
Container-title:Frontiers in Bioscience
language:en
Short-container-title:Front Biosci

Author:

Raza Sana

Publisher

IMR Press

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of mobile health intervention for non alcoholic fatty liver disease- A meta analysis of randomized controlled trials;Clinics and Research in Hepatology and Gastroenterology;2024-10

2. Effect of Ilex hainanensis Merr. On HFD-induced nonalcoholic fatty liver disease and rebalance of gut microbiota and bile acids metabolism in mice;Fitoterapia;2024-10

3. Effects of 12-weeks resistance training and vitamin E supplementation on aminotransferases, CTRP-2, and CTRP-9 levels in males with nonalcoholic fatty liver disease: a double-blind, randomized trial;BMC Sports Science, Medicine and Rehabilitation;2024-09-04

4. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review;Pharmacological Research - Modern Chinese Medicine;2024-09

5. Gypensapogenin A-Liposomes Efficiently Ameliorates Hepatocellular Lipid Accumulation via Activation of FXR Receptor;Molecules;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3